Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1423-0208|17|1|14-20

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.17, Iss.1, 1998-03, pp. : 14-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of the Apolipoprotein E ε4 Allele on the Efficacy and Tolerability of Galantamine in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 1, 2005-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Differentiates the Clinical Response to Donepezil in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 4, 2005-09 ,pp. : 254-261

Karger

Access to resources Recommend Favorite

Depression in Alzheimer’s Disease Might Be Associated with Apolipoprotein E ε4 Allele Frequency in Women but Not in Men

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 59-63

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Is Unrelated to Cognitive or Functional Decline in Alzheimer’s Disease: Retrospective and Prospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 1, 2006-06 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

Apolipoprotein E ε4 Allele Frequency and Age at Onset of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 1, 2006-11 ,pp. : 60-66

Karger

Access to resources Recommend Favorite